Genome-wide association study follow-up identifies cyclin A2 as a regulator of the transition through cytokinesis during terminal erythropoiesis.

Am J Hematol

Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts; Institute for Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany; Charité-Universitätsmedizin Berlin, Berlin, Germany.

Published: May 2015

Genome-wide association studies (GWAS) hold tremendous promise to improve our understanding of human biology. Recent GWAS have revealed over 75 loci associated with erythroid traits, including the 4q27 locus that is associated with red blood cell size (mean corpuscular volume). The close linkage disequilibrium block at this locus harbors the CCNA2 gene that encodes cyclin A2. CCNA2 mRNA is highly expressed in human and murine erythroid progenitor cells and regulated by the essential erythroid transcription factor GATA1. To understand the role of cyclin A2 in erythropoiesis, we have reduced expression of this gene using short hairpin RNAs in a primary murine erythroid culture system. We demonstrate that cyclin A2 levels affect erythroid cell size by regulating the passage through cytokinesis during the final cell division of terminal erythropoiesis. Our study provides new insight into cell cycle regulation during terminal erythropoiesis and more generally illustrates the value of functional GWAS follow-up to gain mechanistic insight into hematopoiesis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409486PMC
http://dx.doi.org/10.1002/ajh.23952DOI Listing

Publication Analysis

Top Keywords

terminal erythropoiesis
12
genome-wide association
8
cell size
8
murine erythroid
8
erythroid
5
association study
4
study follow-up
4
follow-up identifies
4
cyclin
4
identifies cyclin
4

Similar Publications

Aims: Blood levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT-proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.

Methods: This post hoc analysis stemmed from the oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN) trial, a large prospective study involving patients with non-dialysis kidney disease experiencing anaemia.

View Article and Find Full Text PDF
Article Synopsis
  • Short-term heat acclimation (HA) for trained athletes boosts sweating adaptations and thermal resilience, but prolonged HA is better for benefits in cooler conditions and red blood cell production.
  • In a study with 20 elite cyclists, those undergoing 5 weeks of HA saw significant improvements in exhaustion time, sweat rates, and reduced sodium concentration after intense heat exposure.
  • However, these benefits diminished quickly after a 2-week break from HA, indicating that while short-term acclimation is effective, the endurance gains may not last long without continued practice.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness and safety of using vadadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, as an alternative to the erythropoiesis-stimulating agent methoxy polyethylene glycol-epoetin beta (MPG-EPO) in treating anemia for patients with chronic kidney disease (CKD) who are on dialysis.
  • This Phase 3b trial involved 456 adult participants, randomized into three groups receiving either vadadustat (at two different doses) or MPG-EPO, for up to 52 weeks, with a focus on changes in hemoglobin levels.
  • Results showed that vadadustat was noninferior to MPG-EPO regarding hemoglobin change
View Article and Find Full Text PDF

DDIT4 promotes erythroid differentiation and coordinates with SIPA1 to regulate erythroid proliferation in bone marrow of high altitude erythrocytosis.

Life Sci

December 2024

Key Laboratory of High Altitude and Frigid zone Medical Support, Chongqing, China; Key Laboratory of Extreme Environmental Medicine, Ministry of Education, Chongqing, China. Electronic address:

Erythrocytosis moderately enhances the oxygen-carrying capacity of the blood and is considered a characteristic response of individuals adapting from low-altitude regions to high-altitude regions. Nevertheless, erythrocytosis can also turn excessive and result in maladaptive syndromes, such as high altitude polycythemia (HAPC). The increased differentiation or proliferation of erythroid cells in the bone marrow may be a crucial factor leading to accumulation of peripheral erythroid cells.

View Article and Find Full Text PDF

New hematopoietic cell models have recently emerged through immortalization of CD34 cells to study and understand various molecular mechanisms of erythropoiesis. Here, we characterize the JK-1 CML-derived cell line, previously shown to spontaneously differentiate without cytokines. Using an epigenetic differentiation inhibitor that keeps JK-1 in an early differentiation phase, we characterized 2 progenitor stages: BFU-E JK-1 and CFU-E JK-1 with CD34+/CD36- and CD34-/CD36 + phenotypes respectively.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!